1.
Almaaytah A, Elhajji FD. Comparative Cost Efficiency of the Originator Drug of Infliximab and its Biosimilar for the Treatment of Rheumatoid Arthritis in the MENA Region. ijpi [Internet]. 31Mar.2019 [cited 17Oct.2019];9(1):12-5. Available from: http://jpionline.org/index.php/ijpi/article/view/311